Target intelligence / Profile preview

Heparin and heparan sulfate-like glycosaminoglycans (HS-GAGs)

Target
HS-GAGs
Molecular classification
Glycosaminoglycan, Polysaccharide, Carbohydrate
01

Overview

Heparin and heparan sulfate-like glycosaminoglycans (HS-GAGs) are complex, linear polysaccharides found on cell surfaces and within the extracellular matrix [2][4]. They are characterized by a high negative charge density due to extensive sulfation, which allows them to interact with a vast array of proteins, including coagulation factors, growth factors, and chemokines [3]. In clinical medicine, heparin and its low-molecular-weight derivatives are gold-standard anticoagulants that function by binding to antithrombin III, significantly accelerating the inactivation of thrombin and Factor Xa [1]. Beyond their role in hematology, HS-GAGs act as essential co-receptors in various cell signaling pathways and serve as primary attachment sites for numerous pathogens, including viruses like SARS-CoV-2 and Herpes Simplex Virus [3]. Their structural diversity and ubiquity make them critical regulators of physiological processes such as angiogenesis, wound healing, and the inflammatory response [2].

Other names
Heparan sulfateHeparinHSGlycosaminoglycansHeparan sulfate proteoglycan chainsHeparinoids
02

Mechanism of action

Drugs targeting these molecules primarily act by potentiating antithrombin III to accelerate the inhibition of coagulation factors like Thrombin (Factor IIa) and Factor Xa, or by competitively inhibiting the binding of endogenous ligands and pathogens to the glycosaminoglycan chains [1][3].

03

Biological functions

AnticoagulationCell signalingCell adhesionGrowth factor sequestrationExtracellular matrix organizationViral entry mediation
04

Disease associations

ThrombosisInflammationCancerViral infectionCardiovascular diseaseAlzheimer's disease
05

Safety considerations

Hemorrhage (bleeding)Heparin-induced thrombocytopenia (HIT)Osteoporosis with long-term useHyperkalemiaHypersensitivity reactions
06

Interacting drugs

Heparin

7 more in the full profile.

07

Biomarkers

Activated partial thromboplastin time (aPTT)Anti-Factor Xa activityPlatelet count

Beyond the preview

Go deeper on Heparin and heparan sulfate-like glycosaminoglycans (HS-GAGs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heparin and heparan sulfate-like glycosaminoglycans (HS-GAGs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call